Ibuprofen Caplets 200mg(2021-04-06)
- Starting date:
- April 6, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-75459
Last updated:
2021-05-18
Summary
-
Product:
Ibuprofen Caplets 200mg
Reason
An impurity is out of specification in the affected lots.
Depth of distribution
Wholesalers
Affected products
Ibuprofen Caplets 200mg
DIN, NPN, DIN-HIM
DIN 02368080
Dosage form
Tablet
Strength
Ibuprofen 200mg
Lot or serial number
0A26850E0,0A26850E3, 0A26850E6,0A26850EM,0A26850EN 0A26850EP, 0A26850ET, 0A26850EQ,0A26850ER, 0A26850ES, 0A26850E1, 0A26850E2, 0A26850CZ, 0A2684Z5G, 0A26850EY, 0A26851FP, 0A26850EV, 0A26850E9, 0A26850EB,0A26850E7, 0A26850E8, 0A26850E4, 0A26850E5, 0A26850F30A26850F1, 0A26953YY, 0A26953YW, 0A26953YX, 0A26953Z0, 0A26953YZ, 0A26953YV, 0A26953Z30A26953YU, 0A26953Z2, 0A26953Z1, 0A26952ER0G01753VY, 0G017544Z, 0G01753VT, 0G01753VU0G01753VZ, 0G01753VF, 0G01753VP, 0G01753W1, 0G01753VG, 0G01753VQ, 0G01753VS, 0G01753VB, 0G01753VW, 0G01753VE, 0G01753V9, 0G01753W0, 0G01753VM, 0G0175409, 0G01753VV, 0G01753W2, 0G01753VX, 0G01753VJ, 0G25054QX, 0G250544Z, 0G25054AP, 0G25053VR, 0G25054PF, 0G250543P, 0G25054P3, 0G25054C4, 0G25053VN, 0G250550L, 0G25054JX, 0G25054QS, 0G25053VW, 0G25054N0, 0G25053VC, 0G25054MZ, 0G25054JF, 0G25054NP, 0G25054N9, 0G250548C, 0G25054QL, 0G25054A7, 0G251557U, 0G25155Z6, 0G25155K4, 0G25155YU, 0G25154JX, 0G25154A7, 0G25154A8, 0G25254A8
Companies
- Recalling Firm
-
Vita Health Products Inc.
150 Beghin Ave.
Winnipeg
R2J 3W2
Manitoba
CANADA
- Marketing Authorization Holder
-
Vita Health Products Inc.
150 Beghin Ave.
Winnipeg
R2J 3W2
Manitoba
CANADA